Miguel Puerro

Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

Francisco J. de Abajo, Sara Rodríguez‐Martín, Victoria Lerma et al. · The Lancet · 2020 · 422 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +7

Effect of Adverse Drug Reactions on Length of Stay in Intensive Care Units

Emilio Vargas, J Cucharero Martín, Miguel Puerro et al. · Clinical Drug Investigation · 1998 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +13

Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study

Francisco J. de Abajo, Antonio Rodríguez, Sara Rodríguez‐Martín et al. · BMC Medicine · 2021 · 20 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

A new high-absorption-rate Paracetamol 500-mg formulation: a comparative bioavailability study in healthy volunteers

Antonio Portolés, Miguel Puerro, Ana Terleira et al. · Current Therapeutic Research · 2003 · 16 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Influence of Genetic Polymorphisms on the Response to Tramadol, Ibuprofen, and the Combination in Patients With Moderate to Severe Pain After Dental Surgery

Miriam Saiz‐Rodríguez, Sarahí Valdez-Acosta, Alberto M. Borobia et al. · Clinical Therapeutics · 2021 · 14 citations

Medicine, Genetics, Pain Medicine +15